Designated organic active ingredient containing (doai) > Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., o,s,se or te) or nitrogen as the only ring hetero atoms doai > Hetero ring is six-membered consisting of one nitrogen and five carbon atoms > Patents

Resources

Home

Browse by:

Browse by Category: Main > Health & Medicine

Class Information
Number: 514/277
Name: Drug, bio-affecting and body treating compositions > Designated organic active ingredient containing (doai) > Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., o,s,se or te) or nitrogen as the only ring hetero atoms doai > Hetero ring is six-membered consisting of one nitrogen and five carbon atoms
Description: Subject matter which contains a six-membered heterocyclic ring consisting of one nitrogen and five carbon atoms.

Sub-classes under this class:

Class Number	Class Name	Patents
514/336	Additional hetero ring containing	850
514/354	C=o bonded directly to the six-membered hetero ring	436
514/345	Chalcogen bonded directly to ring carbon of the six-membered hetero ring	722
514/344	Cyano bonded directly to the six-membered hetero ring	250
514/352	Nitrogen attached directly to the six-membered hetero ring by nonionic bonding	779
514/357	Nitrogen attached indirectly to the six-membered hetero ring by nonionic bonding	1,297
514/315	Piperidines	784
514/332	Plural six-membered hetero rings consisting of one nitrogen and five carbon atoms	547
514/279	Polycyclo ring system having the six-membered hetero ring as one of the cyclos	278
514/278	Spiro ring system	798
514/358	The ring nitrogen of the six-membered hetero ring is pentavalent (e.g., quaternary pyridinium salt, etc.)	152

Patents under this class:

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

Patent Number	Title Of Patent	Date Issued
6303660	Enhanced anti-cancer agent delivery to solid tumors by primer compounds	Oct. 16, 2001
6300352	Pyridine derivatives and pharmaceutical compositions containing them	Oct. 9, 2001
6300324	Composition for repelling ticks	Oct. 9, 2001
6297290	Composition containing a nerve fiber reactivity modulating compound	Oct. 2, 2001
6297264	Trisubstituted phenyl derivatives and process for their preparation	Oct. 2, 2001
6294544	Peripheral circulation improvers for ophthalmic tissues containing dihydropyridines	Sep. 25, 2001
6291533	Dietary supplements for each specific blood type	Sep. 18, 2001
6288091	Antiherpes virus compounds and methods for their preparation and use	Sep. 11, 2001
6288074	Method of treating lymphoproliferative syndrome	Sep. 11, 2001
6284768	Src family SH2 domain inhibitors	Sep. 4, 2001
6281233	Method of treating gastrointestinal motility disorders	Aug. 28, 2001
6281232	Method of treating gastrointestinal motility disorders	Aug. 28, 2001
6281231	2,6-dichloro-4-pyridinemethanol derivatives and agricultural chemicals	Aug. 28, 2001
6274570	Pesticidal compositions	Aug. 14, 2001
6274590	Method of treating skin related conditions	Aug. 14, 2001
6268377	Method for treating androgen-related conditions	Jul. 31, 2001
6265409	Pyridine derivatives and pharmaceutical compositions containing them	Jul. 24, 2001
6262104	Diarylalkenylamine derivatives	Jul. 17, 2001
6255340	Pesticidal composition	Jul. 3, 2001
6251898	Medical use of fluorenone derivatives for treating and preventing brain and spinal injury	Jun. 26, 2001
6248744	Method for the treatment of pain, including chronic and female specific pain	Jun. 19, 2001
6245774	Tri-substituted phenyl or pyridine derivatives	Jun. 12, 2001
6239138	Vitronectin receptor antagonist	May. 29, 2001
6239148	N-substituted azaheterocyclic carboxylic acids and esters thereof	May. 29, 2001
6239175	Carbamoyloxy derivatives of mutiline and their use as antibacterials	May. 29, 2001
6235755	FSH mimetics for the treatment of infertility	May. 22, 2001
6235509	Process for inhibiting serine proteases using cresol or 3-hydroxypyridine and sulfonic acid derivatives or fluorophosphonates	May. 22, 2001
6232319	Substituted tetrahydropyridin derivatives, method of preparation and pharmaceutical compositions containing them	May. 15, 2001
6228878	Methods for treating or preventing alzheimer's disease using substituted 2-aryl-3-morpholinopropanones	May. 8, 2001
6228862	Treating NIDDM with RXR agonists	May. 8, 2001
6228400	Orally administered pharmaceutical formulations of benzimidazole derivatives and the method of preparing the same	May. 8, 2001
6214835	Dihalopropene compounds insecticides containing them as active ingredients, and intermediates for their production	Apr. 10, 2001
6207671	Cycloalkano-pyridines	Mar. 27, 2001
6204277	Propionic acid derivatives and applications thereof	Mar. 20, 2001
6200982	Substituted 1H-pyridinyl-2-ones as GABAA-.alpha. 2/3 ligands	Mar. 13, 2001
6194421	Inhibitors of metazoan parasite proteases	Feb. 27, 2001
6194435	Lactams as selective factor Xa inhibitors	Feb. 27, 2001
6191137	Pharmaceutical composition for oral administration	Feb. 20, 2001
6187806	N-linked sulfone of heterocyclic thioester hair growth compositions and uses	Feb. 13, 2001
6174901	Substituted pyridine and pyridazine compounds and methods of use	Jan. 16, 2001
6168808	Synergistic composition of peracetic acid and amine oxide	Jan. 2, 2001
6166004	Combinations of HIV protease inhibitors with reverse transcriptase inhibitors	Dec. 26, 2000
6166028	Diaminopuridine-containing thiourea inhibitors of herpes viruses	Dec. 26, 2000
6162810	Inadone and tetralone compounds for inhibiting cell proliferation	Dec. 19, 2000
6159983	Method and composition for treatment of inflammatory bowel disease	Dec. 12, 2000
6156761	Substituted tetralone derivatives for enhancing cognition	Dec. 5, 2000
6150413	Triaromatic compounds and pharmaceutical/cosmetic compositions comprised thereof	Nov. 21, 2000
6147082	Chalcones having antiproliferative activity	Nov. 14, 2000
6147081	Ophthalmic solution	Nov. 14, 2000
6143755	Pharmaceutical methods of treatment with ACAT inhibitors and HMG-CoA reductase inhibitors	Nov. 7, 2000